Cargando…

UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study

Bladder cancer is the fourth most common cancer in men and the fifth most common cancer worldwide. UroVysion FISH has high sensitivity and specificity for urothelial carcinoma detection. We investigated the genetic marker detected by the UroVysion FISH technique in diagnosis of Turkish bladder cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dodurga, Yavuz, Avcı, Çığır Biray, Yılmaz, Sunde, Nazlı, Oktay, Çoğulu, Özgür, Cankaya, Tufan, Gündüz, Cumhur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685372/ https://www.ncbi.nlm.nih.gov/pubmed/23788983 http://dx.doi.org/10.5114/wo.2013.34619

Ejemplares similares

Evaluation of UroVysion for Urachal Carcinoma Detection
por: Hu, Zhiquan, et al.
Publicado: (2020)

Refined pancreatobiliary UroVysion criteria and an approach for further optimization
por: Mettman, Daniel, et al.
Publicado: (2021)

A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
por: Lavery, Hugh J., et al.
Publicado: (2017)

Performance of the UroVysion (®) FISH assay for the diagnosis of malignant effusions using two cutoff strategies
por: Rosolen, Débora C. B., et al.
Publicado: (2018)

UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives
por: Nagai, Takashi, et al.
Publicado: (2021)

Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
por: Kurien, Annamma, et al.
Publicado: (2007)

UroVysion(TM) Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives
por: Ke, Chunjin, et al.
Publicado: (2022)

AB051. Comparison of urine cytology and UroVysion FISH for upper tract urothelial carcinoma detection in Chinese patients
por: Peng, Weibin, et al.
Publicado: (2016)

Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens
por: Chang, Sue, et al.
Publicado: (2015)

Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients
por: Nagai, Takashi, et al.
Publicado: (2019)

UroVysion(™) fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
por: Ke, Chunjin, et al.
Publicado: (2023)

Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test
por: Kavcic, Niko, et al.
Publicado: (2022)

Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan
por: Ikeda, Atsushi, et al.
Publicado: (2020)

A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets
por: Breen, Vivienne, et al.
Publicado: (2015)

Genistein-induced mir-23b expression inhibits the growth of breast cancer cells
por: Avci, Cigir Biray, et al.
Publicado: (2014)

Nefro-Uro /
Publicado: (2018)

Essentials of Uro-Radiology
por: Kabala, J. E.
Publicado: (1991)

Haema-Uro-Chrome
Publicado: (1914)

Serum 8-OHdG and HIF-1α levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?
por: Ece, Harman, et al.
Publicado: (2013)

Robotics in uro-oncologic surgery
por: De Lorenzis, Elisa, et al.
Publicado: (2013)

The effect of caffeic acid phenethyl ester on cell cycle control gene expressions in breast cancer cells
por: Balc-Okcanoğlu, Tuğçe, et al.
Publicado: (2021)

Positron emission tomography in uro-oncology
por: Hain, S F
Publicado: (2005)

Enhanced Anti-cancer Potency Using a Combination of Oleanolic Acid and Maslinic Acid to Control Treatment Resistance in Breast Cancer
por: Avcı, Cigir Biray, et al.
Publicado: (2023)

Kidney and uro-trauma: WSES-AAST guidelines
por: Coccolini, Federico, et al.
Publicado: (2019)

Renal actinomycosis presenting as uro-cutaneous fistula
por: Diab, Christian, et al.
Publicado: (2019)

Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients
por: Kim, Tae-Jung, et al.
Publicado: (2019)

Phylogenetic analysis of uroporphyrinogen III synthase (UROS) gene
por: Shaik, Abjal Pasha, et al.
Publicado: (2012)

Use of the Uro Dyna-CT in endourology – the new frontier
por: Vicentini, Fabio C., et al.
Publicado: (2017)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

Adrenal Rests in the Uro-genital Tract of an Adult Population
por: Falco, Enrico Costantino, et al.
Publicado: (2021)

Uro-Genital Tuberculosis: With Especial Consideration of Tuberculosis of the Bladder
por: Lewis, Bransford
Publicado: (1909)

Management of female uro-genital fistulas: Framing certain guidelines
por: Singh, R. B., et al.
Publicado: (2010)

AB049. The importance of Uro-Andro-check in sexual medicine
por: Soebadi, Doddy M.
Publicado: (2015)

Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers
por: Pichler, Renate
Publicado: (2020)

Evaluation of the Endo-Uro trainer for semi-rigid ureteroscopy training
por: Palaneer, Sharanya, et al.
Publicado: (2019)

COVID-19 research: promising tracks leading to uro-oncology
por: Tamás, Fazekas, et al.
Publicado: (2020)

Uro-lymphatic fistula associated with urolithiasis: A case report
por: Tsuboi, Keisuke, et al.
Publicado: (2022)

Value of multiphoton microscopy in uro-oncology: a narrative review
por: Treacy, Patrick-Julien, et al.
Publicado: (2023)

Hema-Uro-Chrome—A New Laboratory Test for Cancer and Sarcoma; from the Urine
Publicado: (1914)

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
por: Bersanelli, Melissa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j6brvmllkl2ojkqqseakdf4kb6